‘Old-School’ Medical Device Weds with ‘Next-Gen’ Digital Platform to Revolutionize Treatment of COPD, CHF, Hypertension and Dysphagia
- Aug 16, 2016
- By Nate Treloar
- In News Release
- Comments Off on ‘Old-School’ Medical Device Weds with ‘Next-Gen’ Digital Platform to Revolutionize Treatment of COPD, CHF, Hypertension and Dysphagia
PN Medical and Orbita develop breakthrough Breather+® respiratory muscle training device and applications for remote care management
BOSTON, MA and ORLANDO, FL, August 16, 2016 /PRWEB/ — PN Medical, an industry leader in pulmonary and speech rehabilitation technology, has chosen Orbita to advance the company’s goals of improving lives and reducing health care costs among patients with chronic conditions such as asthma, chronic obstructive pulmonary disease (COPD,) congestive heart failure (CHF,) hypertension and dysphagia. PN Medical will leverage Orbita’s unique digital platform to enable clinicians to better monitor and support patients undergoing therapy for these conditions at home.
PN Medical’s newest device, Breather+™, is a Bluetooth-enabled respiratory muscle training (RMT) device for patients with abnormal breathing function or shortness of breath as well as problems with speech and swallowing due to decreased breath support. It is used both diagnostically to measure lung capacity and therapeutically to improve breathing function as patients perform inhaling and exhaling exercises. Sensors embedded in the Breather+ capture lung function and patient adherence data. That data is instantly sent to the Orbita-powered practitioner dashboard via the Breather+ mobile app and provides meaningful information to monitor and manage patients.
“In 1980, we were first to market with The Breather™, our revolutionary respiratory device. Now, thanks to our partnership with Orbita, we’re leading the way again in transforming healthcare at home,” said PN Medical’s CEO Mark A. Carbone. “We are thrilled to partner with Orbita, the only technology provider that met all of our requirements for creating this smart, connected care application.”
The Breather+ device and platform supports early intervention and more targeted, personalized treatment which Carbone says will not only reduce emergency room visits, but also improve patient’s quality of life as the original Breather has been doing for 30 years.
“We are pleased to partner with such an innovative company as PN Medical to bring this intelligent, connected home care management solution to market,” said Orbita CEO Bill Rogers. “We are seeing just how powerful technology can be in solving patient adherence challenges and addressing fragmented communication and collaboration among patients, their caregivers and clinicians. It’s all about engaging patients, informing caregivers and empowering providers.”
Carbone’s passion with PN Medical was inspired after seeing both of his parents struggle with significant cardiac and pulmonary conditions. “I witnessed the patient/provider breakdown firsthand and was emboldened to find a way to do something about it,” he said. “Anything to keep my dad from going back to the hospital when he could stay home was his wish to me. This new technology is allowing us to do just that.”
Orbita provides the first secure (HIPAA-compliant) cloud-based platform for creating and managing digital home healthcare applications. Orbita’s purpose-built platform gathers data from wearables, home health devices, and other connected devices into collaborative care experiences that vastly improve patient engagement and care coordination. Orbita works with healthcare providers, payers, home care service providers, medical device manufacturers, and other healthcare organizations to enable digital home healthcare solutions that increase treatment adherence, improve outcomes, reduce costs, and minimize risks for patients with chronic or post-acute healthcare needs. www.orbitahealth.com
ABOUT PN MEDICAL
PN Medical’s purpose for existing is to improve patients’ quality of life every time they put one of their devices in their mouth. They have over a million of their original devices on the market, a respiratory muscle trainer (RMT) named, The Breather™. Their next-gen device, Breather+ integrates spirometry diagnostics, RMT therapeutics, and remote patient monitoring. www.pnmedical.com
Contact: Beth Strohbusch